0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Researchers at Virginia Tech develop a new cancer immunotherapy that uses cytokine proteins to target and eliminate tumor cells without harming healthy cells, offering a safer and more effective alternative to current treatments.